Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
2002 4
2003 2
2004 4
2005 2
2006 5
2007 3
2008 8
2009 15
2010 5
2011 5
2012 10
2013 23
2014 7
2015 5
2016 12
2017 13
2018 12
2019 5
2020 11
2021 4
2022 9
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

169 results

Results by year

Filters applied: . Clear all
Page 1
Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia.
Wang Q, Cai WZ, Wang QR, Zhu MQ, Yan LZ, Yu Y, Bao XB, Shen HJ, Yao H, Xie JD, Zhang TT, Zhang L, Xu XY, Shan Z, Liu H, Cen JN, Liu DD, Pan JL, Lu DR, Chen J, Xu Y, Zhang R, Wang Y, Xue SL, Miao M, Han Y, Tang XW, Qiu HY, Sun AN, Huang JY, Dai HP, Wu DP, Chen SN. Wang Q, et al. Among authors: sun an. Am J Hematol. 2023 Jan;98(1):66-78. doi: 10.1002/ajh.26758. Epub 2022 Oct 31. Am J Hematol. 2023. PMID: 36219502 Free article.
Investigation of the risk factors to predict cytokine release syndrome in relapsed or refractory B-cell acute lymphoblastic leukemia patients receiving IL-6 knocking down anti-CD19 chimeric antigen receptor T-cell therapy.
Gong WJ, Qiu Y, Li MH, Chen LY, Li YY, Yu JQ, Kang LQ, Sun AN, Wu DP, Yu L, Xue SL. Gong WJ, et al. Among authors: sun an. Front Immunol. 2022 Aug 29;13:922212. doi: 10.3389/fimmu.2022.922212. eCollection 2022. Front Immunol. 2022. PMID: 36105799 Free PMC article. Clinical Trial.
[An experimental study of CD4 targeted chimeric antigen receptor modified T cell with anti-lymphoma activity].
Chen GH, Huang HW, Wang Y, Liu HW, Xu LJ, Ma X, Xue SL, He XF, Wang Y, Gu B, Li CX, Qiu HY, Tang XW, Jin ZM, Miao M, Sun AN, Wu DP. Chen GH, et al. Among authors: sun an. Zhonghua Xue Ye Xue Za Zhi. 2018 Feb 14;39(2):148-152. doi: 10.3760/cma.j.issn.0253-2727.2018.02.014. Zhonghua Xue Ye Xue Za Zhi. 2018. PMID: 29562451 Free PMC article. Chinese.
169 results